
|Videos|October 6, 2022
Treatment Goals for Patients with Myelodysplastic Syndrome
Author(s)Hetty E. Carraway, MD, Eytan M. Stein, MD
Experts explain the treatment goals for patients with MDS, and discusses the role of molecular testing in patients with MDS.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5













































